RUNX1 and neoplasm: Meanwhile, analyses of the RUNX1 transcriptional networks in previous studies have documented the activation of tumor suppressors, such as p19 [27] or p21 [28], or the inhibition of oncogenes by RUNX1 binding [29] for cancer progression.